Literature DB >> 29785028

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.

Renée Beekman1,2, Vicente Chapaprieta3, Núria Russiñol1, Roser Vilarrasa-Blasi3, Núria Verdaguer-Dot3, Joost H A Martens4, Martí Duran-Ferrer3, Marta Kulis5, François Serra6,7,8, Biola M Javierre9, Steven W Wingett9, Guillem Clot1,2, Ana C Queirós1, Giancarlo Castellano10, Julie Blanc6,11, Marta Gut6,11, Angelika Merkel6,11, Simon Heath6,11, Anna Vlasova12, Sebastian Ullrich12, Emilio Palumbo12, Anna Enjuanes1,2, David Martín-García1,2, Sílvia Beà1,2, Magda Pinyol1,2, Marta Aymerich2,13, Romina Royo14, Montserrat Puiggros14, David Torrents14,15, Avik Datta16, Ernesto Lowy16, Myrto Kostadima16, Maša Roller16, Laura Clarke16, Paul Flicek16, Xabier Agirre2,17, Felipe Prosper2,17,18, Tycho Baumann2,19, Julio Delgado2,19, Armando López-Guillermo2,19, Peter Fraser9,20, Marie-Laure Yaspo21, Roderic Guigó12, Reiner Siebert22, Marc A Martí-Renom6,7,8,15, Xose S Puente2,23, Carlos López-Otín2,23, Ivo Gut6,11, Hendrik G Stunnenberg4, Elias Campo1,2,3,5,24, Jose I Martin-Subero25,26,27.   

Abstract

Chronic lymphocytic leukemia (CLL) is a frequent hematological neoplasm in which underlying epigenetic alterations are only partially understood. Here, we analyze the reference epigenome of seven primary CLLs and the regulatory chromatin landscape of 107 primary cases in the context of normal B cell differentiation. We identify that the CLL chromatin landscape is largely influenced by distinct dynamics during normal B cell maturation. Beyond this, we define extensive catalogues of regulatory elements de novo reprogrammed in CLL as a whole and in its major clinico-biological subtypes classified by IGHV somatic hypermutation levels. We uncover that IGHV-unmutated CLLs harbor more active and open chromatin than IGHV-mutated cases. Furthermore, we show that de novo active regions in CLL are enriched for NFAT, FOX and TCF/LEF transcription factor family binding sites. Although most genetic alterations are not associated with consistent epigenetic profiles, CLLs with MYD88 mutations and trisomy 12 show distinct chromatin configurations. Furthermore, we observe that non-coding mutations in IGHV-mutated CLLs are enriched in H3K27ac-associated regulatory elements outside accessible chromatin. Overall, this study provides an integrative portrait of the CLL epigenome, identifies extensive networks of altered regulatory elements and sheds light on the relationship between the genetic and epigenetic architecture of the disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29785028      PMCID: PMC6363101          DOI: 10.1038/s41591-018-0028-4

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  72 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.

Authors:  G M Kasof; J J Lu; D Liu; B Speer; K N Mongan; B C Gomes; M V Lorenzi
Journal:  Oncogene       Date:  2001-11-29       Impact factor: 9.867

3.  A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Michele Ceribelli; Zhiying Esther Hou; Priscilla N Kelly; Da Wei Huang; George Wright; Karthik Ganapathi; Moses O Evbuomwan; Stefania Pittaluga; Arthur L Shaffer; Guido Marcucci; Stephen J Forman; Wenming Xiao; Rajarshi Guha; Xiaohu Zhang; Marc Ferrer; Laurence Chaperot; Joel Plumas; Elaine S Jaffe; Craig J Thomas; Boris Reizis; Louis M Staudt
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

4.  Chromatin organization is a major influence on regional mutation rates in human cancer cells.

Authors:  Benjamin Schuster-Böckler; Ben Lehner
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

5.  Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Kendell Clement; Michael J Ziller; Patrick Boyle; Jean Fan; Hongcang Gu; Kristen Stevenson; Carrie Sougnez; Lili Wang; Shuqiang Li; Dylan Kotliar; Wandi Zhang; Mahmoud Ghandi; Levi Garraway; Stacey M Fernandes; Kenneth J Livak; Stacey Gabriel; Andreas Gnirke; Eric S Lander; Jennifer R Brown; Donna Neuberg; Peter V Kharchenko; Nir Hacohen; Gad Getz; Alexander Meissner; Catherine J Wu
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

6.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

7.  Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elements.

Authors:  Masafumi Muratani; Niantao Deng; Wen Fong Ooi; Suling Joyce Lin; Manjie Xing; Chang Xu; Aditi Qamra; Su Ting Tay; Simeen Malik; Jeanie Wu; Ming Hui Lee; Shenli Zhang; Luke Lin Chuen Tan; Huihoon Chua; Wai Keong Wong; Hock Soo Ong; London Lucien Ooi; Pierce Kah-How Chow; Weng Hoong Chan; Khee Chee Soo; Liang Kee Goh; Steve Rozen; Bin Tean Teh; Qiang Yu; Huck Hui Ng; Patrick Tan
Journal:  Nat Commun       Date:  2014-07-10       Impact factor: 14.919

8.  Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.

Authors:  John C Riches; Conor J O'Donovan; Sarah J Kingdon; Fabienne McClanahan; Andrew J Clear; Donna S Neuberg; Lillian Werner; Carlo M Croce; Alan G Ramsay; Laura Z Rassenti; Thomas J Kipps; John G Gribben
Journal:  Blood       Date:  2014-05-14       Impact factor: 22.113

9.  Mapping and analysis of chromatin state dynamics in nine human cell types.

Authors:  Jason Ernst; Pouya Kheradpour; Tarjei S Mikkelsen; Noam Shoresh; Lucas D Ward; Charles B Epstein; Xiaolan Zhang; Li Wang; Robbyn Issner; Michael Coyne; Manching Ku; Timothy Durham; Manolis Kellis; Bradley E Bernstein
Journal:  Nature       Date:  2011-03-23       Impact factor: 49.962

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  66 in total

1.  Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Authors:  Christopher J Ott; Alexander J Federation; Logan S Schwartz; Siddha Kasar; Josephine L Klitgaard; Romina Lenci; Qiyuan Li; Matthew Lawlor; Stacey M Fernandes; Amanda Souza; Donald Polaski; Deepti Gadi; Matthew L Freedman; Jennifer R Brown; James E Bradner
Journal:  Cancer Cell       Date:  2018-11-29       Impact factor: 31.743

2.  CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.

Authors:  David Martín-Garcia; Alba Navarro; Rafael Valdés-Mas; Guillem Clot; Jesús Gutiérrez-Abril; Miriam Prieto; Inmaculada Ribera-Cortada; Renata Woroniecka; Grzegorz Rymkiewicz; Susanne Bens; Laurence de Leval; Andreas Rosenwald; Judith A Ferry; Eric D Hsi; Kai Fu; Jan Delabie; Dennis Weisenburger; Daphne de Jong; Fina Climent; Sheila J O'Connor; Steven H Swerdlow; David Torrents; Sergi Beltran; Blanca Espinet; Blanca González-Farré; Luis Veloza; Dolors Costa; Estella Matutes; Reiner Siebert; German Ott; Leticia Quintanilla-Martinez; Elaine S Jaffe; Carlos López-Otín; Itziar Salaverria; Xose S Puente; Elias Campo; Sílvia Beà
Journal:  Blood       Date:  2018-12-11       Impact factor: 22.113

3.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

4.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Blood Adv       Date:  2019-11-26

Review 5.  Molecular networks in Network Medicine: Development and applications.

Authors:  Edwin K Silverman; Harald H H W Schmidt; Eleni Anastasiadou; Lucia Altucci; Marco Angelini; Lina Badimon; Jean-Luc Balligand; Giuditta Benincasa; Giovambattista Capasso; Federica Conte; Antonella Di Costanzo; Lorenzo Farina; Giulia Fiscon; Laurent Gatto; Michele Gentili; Joseph Loscalzo; Cinzia Marchese; Claudio Napoli; Paola Paci; Manuela Petti; John Quackenbush; Paolo Tieri; Davide Viggiano; Gemma Vilahur; Kimberly Glass; Jan Baumbach
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-04-19

Review 6.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

7.  Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.

Authors:  Tomasz K Wojdacz; Harindra E Amarasinghe; Latha Kadalayil; Alice Beattie; Jade Forster; Stuart J Blakemore; Helen Parker; Dean Bryant; Marta Larrayoz; Ruth Clifford; Pauline Robbe; Zadie A Davis; Monica Else; Dena R Howard; Basile Stamatopoulos; Andrew J Steele; Richard Rosenquist; Andrew Collins; Andrew R Pettitt; Peter Hillmen; Christoph Plass; Anna Schuh; Daniel Catovsky; David G Oscier; Matthew J J Rose-Zerilli; Christopher C Oakes; Jonathan C Strefford
Journal:  Blood Adv       Date:  2019-08-27

8.  CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation.

Authors:  Boris A Bartholdy; Xiahoua Wang; Xiao-Jie Yan; Marién Pascual; Manxia Fan; Jacqueline Barrientos; Steven L Allen; Jose Angel Martinez-Climent; Kanti R Rai; Nicholas Chiorazzi; Matthew D Scharff; Sergio Roa
Journal:  Blood Adv       Date:  2020-03-10

Review 9.  Epigenetic dynamics in normal and malignant B cells: die a hero or live to become a villain.

Authors:  Jared M Andrews; Jacqueline E Payton
Journal:  Curr Opin Immunol       Date:  2018-10-17       Impact factor: 7.486

Review 10.  Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.

Authors:  Anna S Nam; Ronan Chaligne; Dan A Landau
Journal:  Nat Rev Genet       Date:  2020-08-17       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.